Journal of the Korean Society of Laryngology, Phoniatrics and Logopedics (대한후두음성언어의학회지)

The Korean Society of Laryngology, Phoniatrics and Logopedics. (대한후두음성언어의학회)
권호 표지
DOI QR코드

DOI QR Code

Differences in Patient Characteristics between Spasmodic Dysphonia and Vocal Tremor

연축성 발성장애와 음성 진전 환자의 감별

  • Son, Hee Young (Department of Otorhinolaryngology, Dongnam Institute of Radiological & Medical Sciences)
  • 손희영 (동남권원자력의학원 이비인후과)
  • Received : 2021.03.11
  • Accepted : 2021.03.26
  • Published : 2021.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Spasmodic dysphonia, essential tremor, and vocal tremor related with Parkinson's disease are different disorders showing fairly similar symptoms such as difficulty in the speech onset, and tremble in the voice. However, the cause and the resulting treatment of these diseases are different. Spasmodic dysphonia is a vocal disorder characterized by spasms of the laryngeal muscles during a speech, invoking broken, tense, forced, and strangled voice patterns. Such difficult-to-treat dysphonia disease is classified as central-origin-focal dystonia, of a yet unknown etiology. Its symptoms arise because of intermittent and involuntary muscle contractions during speech. Essential tremor, on the other hand, is characterized by a rhythmic laryngeal movement, resulting in alterations of rhythmic pitch and loudness during speech or even at rest. Severe cases of tremor may cause speech breaks like those of adductor spasmodic dysphonia. In the case of hyper-functional tension of vocal folds and accompanying tremors, it is necessary to distinguish these disorders from muscular dysfunction. A diversified assessment through the performance of specific speech tasks and a thorough understanding for the identification of the disorder is necessary for accurate diagnosis and effective treatment of patients with vocal tremors.

Keywords

References

  1. Kirke DN, Battistella G, Kumar V, Rubien-Thomas E, Choy M, Rumbach A, et al. Neural correlates of dystonic tremor: a multimodal study of voice tremor in spasmodic dysphonia. Brain Imaging Behav 2017;11(1):166-75. https://doi.org/10.1007/s11682-016-9513-x
  2. Ludlow CL, Adler CH, Berke GS, Bielamowicz SA, Blitzer A, Bressman SB, et al. Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg 2008;139(4):495-505. https://doi.org/10.1016/j.otohns.2008.05.624
  3. Ludlow CL, Domangue R, Sharma D, Jinnah HA, Perlmutter JS, Berke G, et al. Consensus-based attributes for identifying patients with spasmodic dysphonia and other voice disorders. JAMA Otolaryngol Head Neck Surg 2018;144(8):657-65. https://doi.org/10.1001/jamaoto.2018.0644
  4. Patel PN, Kabagambe EK, Starkweather JC, Keller M, Ahmed ZA, Gruber SC, et al. Defining differences in patient characteristics between spasmodic dysphonia and laryngeal tremor. Laryngoscope 2019;129(1):170-6. https://doi.org/10.1002/lary.27245
  5. Kwon TK, Son HY. Movement disorders affecting the larynx. J Korean Soc Laryngol Phoniatr Logop 2010;21(1):22-6.
  6. Kwon MS, Sim HS, Chung SJ, Lee JH. A case of spasmodic dysphonia after a right hemispheric lesion. Dementia and Neurocognitive Disorders 2003;2(1):84-7.
  7. Kim YH. Laryngeal neurophysiology. Korean J Otolaryngol-Head Neck Surg 2003;46(10):799-807.
  8. Yang Y. Spasmodic dysphonia. Korean J Otolaryngol-Head Neck Surg 2010;53(9):519-26.
  9. Kim SW, Park YH. Resting-state functional connectivity mediating for phonation by the thalamus in Parkinson's disease. Commun Sci Disord 2020;25(2):470-9.
  10. Kim SY, Lee SH. Differential diagnosis between neurogenic and functional dysphonia. J Korean Soc Laryngol Phoniatr Logop 2017;28(2):71-8. https://doi.org/10.22469/jkslp.2017.28.2.71
  11. Rees CJ, Blalock PD, Kemp SE, Halum SL, Koufman JA. Differentiation of adductor-type spasmodic dysphonia from muscle tension dysphonia by spectral analysis. Otolaryngol Head Neck Surg 2007;137(4):576-81. https://doi.org/10.1016/j.otohns.2007.03.040
  12. Ko H, Choi HS, Lim SE, Choi Y. The aspect of voice characteristics change after botulinum toxin-a injection in patients with adductor spasmodic dysphonia according to vocal tremor. Phonetics Speech Sci 2012;4(4):95-107. https://doi.org/10.13064/KSSS.2012.4.4.095
  13. Gillivan-Murphy P, Miller N. Voice tremor: what we know and what we do not know. Curr Opin Otolaryngol Head Neck Surg 2011;19(3):155-9. https://doi.org/10.1097/MOO.0b013e328345970c
  14. Pearson EJ, Sapienza CM. Historical approaches to the treatment of adductor-type spasmodic dysphonia (ADSD): review and tutorial. NeuroRehabilitation 2003;18(4):325-38. https://doi.org/10.3233/nre-2003-18407
  15. Barkmeier JM, Case JL, Ludlow CL. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges. J Commun Disord 2001;34(1-2):21-37. https://doi.org/10.1016/S0021-9924(00)00039-3
  16. Roy N, Whitchurch M, Merrill RM, Houtz D, Smith ME. Differential diagnosis of adductor spasmodic dysphonia and muscle tension dysphonia using phonatory break analysis. Laryngoscope 2008;118(12):2245-53. https://doi.org/10.1097/MLG.0b013e318184577c
  17. Imamura R, Tsuji DH. Adduction spasmodic dysphonia, vocal tremor and muscular tension dysphonia: is it possible to reach a differential diagnosis? Braz J Otorhinolaryngol 2006;72(4):434. https://doi.org/10.1016/S1808-8694(15)30985-X
  18. Cho JK, Choi SH, Lee SH, Jin SM. Development of differential diagnosis scale items for adductor spasmodic dysphonia and evaluation of clinical availability. J Korean Soc Laryngol Phoniatr Logop 2019; 30(2):112-7.
  19. Choi HS, Lee JH, Kim IS, Koh YW, Oh JS, Yoon HC, Choi SH. The acoustic and aerodynamic aspects of patients with spasmodic dysphonia. J Korean Soc Laryngol Phoniatr Logop 2000;11(1):98-103.
  20. Tsuji DH, Takahashi MT, Imamura R, Hachiya A, Sennes LU. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality. J Voice 2012;26(5):666.e7-12. https://doi.org/10.1016/j.jvoice.2011.07.009
  21. Schuering JHC, Heijnen BJ, Sjogren EV, Langeveld APM. Adductor spasmodic dysphonia: botulinum toxin a injections or laser thyroarytenoid myoneurectomy? A comparison from the patient perspective. Laryngoscope 2020;130(3):741-6. https://doi.org/10.1002/lary.28105
  22. Kim HS, Choi HS, Lim JY, Choi YL, Lim SE. Radiofrequency thyroarytenoid myothermy for treatment of adductor spasmodic dysphonia: how we do it. Clin Otolaryngol 2008;33(6):621-5. https://doi.org/10.1111/j.1749-4486.2008.01777.x
  23. Sanabria J, Ruiz PG, Gutierrez R, Marquez F, Escobar P, Gentil M, et al. The effect of levodopa on vocal function in Parkinson's disease. Clin Neuropharmacol 2001;24(2):99-102. https://doi.org/10.1097/00002826-200103000-00006